Ahmed Abdullah, MD
Obstetrics · Flint, MINPI 1437503455
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $533 and has fallen 79.7% since, to $108 in 2025.
Across 49 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aspira Women's Health Inc$282
- Baxter Healthcare$191
- Astellas Pharma US Inc$144
- Biogen$127
- Novo Nordisk$82
- Pfizer$71
- plus $291 from 12 others
What the payments were for
- Food & beverage$1,16198%
- Other$282%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aspira Women's Health Inc | 6 | $282 |
| Baxter Healthcare | 7 | $191 |
| Astellas Pharma US Inc | 8 | $144 |
| Biogen | 5 | $127 |
| Novo Nordisk | 5 | $82 |
| Pfizer | 4 | $71 |
| Organon | 2 | $51 |
| Gynesonics, Inc. | 1 | $36 |
| Medicem Inc. | 1 | $33 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Exact Sciences | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Coopersurgical, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| LSI Solutions Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
How this compares
$1,188 in reported general payments places this provider in the 55th percentile of 48 obstetrics providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $646 |
| Norethindrone Acetate | 13 | $256 |
Paid to pharmacies, not to this prescriber.
Other obstetrics in Flint
- Carol PowersFlint$327K
- Alexey LevashkevichFlint$23K
- Richard ElsworthFlint$17K
- Anton StrocelFlint$1K
- Breanna PondMarquette$18K
- Salvatore FinazzoTrenton$13K
- Jack ParksMuskegon$10K
- Joseph PrezzatoFarmington Hills$5K
- Duane KreilDearborn$5K
- Michael ShuWyandotte$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.